Previous Video Next Video

video thumbnail

Favipiravir

Duration: 26:05

Write A New Comment

0 Comments

Glenmark's FabiFlu approved for coronavirus treatment in India, costs Rs 103 per tablet

Mumbai-based Glenmark Pharmaceuticals have launched a new antiviral drug - Favipiravir with brand name FabiFlu - for the treatment of mild to moderate Covid-19 patients. The firm has become the first Indian company to commercially launch the antiviral drug.

https://www.indiatoday.in/india/story/coronavirus-treatment-drug-glenmark-fabiflu-favipiravir-launch-india-rs-103-per-tablet-reduce-viral-load-1691066-2020-06-20

Coronavirus replication

https://www.ncbi.nlm.nih.gov/books/NBK554776/figure/article-52171.image.f1/

RdRp is the main enzyme of transcription-replication complex

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2322833/

Favipiravir mechanism of action and its study

https://www.biorxiv.org/content/10.1101/2020.05.15.098731v1.full.pdf+html

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

https://www.sciencedirect.com/science/article/pii/S2095809920300631?via%3Dihub

Potential coronavirus drug approved for marketing

Favipiravir, an antiviral that has shown potential in treating the novel coronavirus, was approved for marketing, the Taizhou government of Zhejiang province announced Sunday.

https://www.chinadaily.com.cn/a/202002/17/WS5e49efc2a310128217277fa3.html

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Therapeutic options in response to the 2019-nCoV outbreak are urgently needed. Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV infection (now known as COVID-19), some of which are already moving into clinical trials.

https://www.nature.com/articles/d41573-020-00016-0

Fujifilm Announces the Start of a Phase III Clinical Trial of Influenza Antiviral Drug Avigan (favipiravir) on COVID-19 in Japan and Commits to Increasing Production

https://www.drugs.com/clinical_trials/fujifilm-announces-start-phase-iii-clinical-trial-influenza-antiviral-avigan-favipiravir-covid-19-18505.html

In this video, Dr. Mobeen will discuss:

1. Studies regarding favipiravir. (2:13)

2. Mechanism of action of favipiravir. (8:15)

3. Important facts about favipiravir. (14:20)

4. End effect of favipiravir. (22:28)

Presented by Dr. Mobeen Syed

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Please login to access this content.

Don't have an account?

See Plans

Instructors

Pharmacology

Videos in Course
Favourite Videos

Clinical Application of Cardiac Drugs/Cardiac Pharmacology

27:29

Ahmed Zaafran, MD

Clinical Applications of Anti-Dysrhythmia Drugs

20:05

Ahmed Zaafran, MD

Clinical Applications of Anti-Inflammatory/Anti-Histamine Drugs

36:23

Ahmed Zaafran, MD

Clinical Applications of Antihypertensive Drugs (Part 1)

19:02

Ahmed Zaafran, MD

Diagnosis and Management of Hypertension

48:55

Ahmed Zaafran, MD

Clinical Application of Cardiac Drugs/Cardiac Pharmacology

27:29

Ahmed Zaafran, MD

0.50 CME

Management of Atrial Fibrillation

34:02

Dr. Mobeen Syed

Cardiac Drugs: Inotropes, Vasopressors, and Vasodilators Part 1

33:33

Luis A Verduzco M.D.

Cardiac Drugs: Inotropes, Vasopressors, and Vasodilators Part 2

48:59

Luis A Verduzco M.D.

0.50 CME

Low Dose Naltrexone (LDN) - Mechanism of Action

34:43

Dr. Mobeen Syed

0.50 CME

Future Antivirals Using Bacterial Immune Sensors

26:02

Dr. Mobeen Syed

(Webinar) Managing Type II Diabetes Mellitus (Part 9)

27:26

Dr. Mobeen Syed

(Webinar) Managing Type II Diabetes Mellitus (Part 10)

29:05

Dr. Mobeen Syed

Metformin and General Considerations to Mange Type II Diabetes Mellitus (Managing Type II Diabetes Mellitus - Part 8. Webinar)

47:37

Dr. Mobeen Syed

Drug Classes to Manage Type II Diabetes Mellitus (Managing Type II Diabetes Mellitus - Part 7. Webinar)

40:48

Dr. Mobeen Syed

(Webinar) Dyslipidemia Management-ACC/AHA guideline Overview

44:42

Dr. Mobeen Syed

1.50 CME

Insulin Synthesis, Secretion, and Regulation

1:34:58

Dr. Mobeen Syed

1.50 CME

Master Insulin Therapy (full video)

1:22:37

Dr. Mobeen Syed

How Does Ozempic Work?

25:07

Dr. Mobeen Syed

0.75 CME

Clinical Application of Cholinergic Drugs/Cholinergic System

51:32

Ahmed Zaafran, MD

0.50 CME

Clinical Applications of Respiratory Drugs (Part 1)/ Asthma

26:05

Ahmed Zaafran, MD

0.50 CME

Clinical Application of Respiratory Drugs (Part2) / Asthma

22:41

Ahmed Zaafran, MD

0.25 CME

Clinical Applications of Anti-Histamine Medications (Part 1)/Common Cold

19:06

Ahmed Zaafran, MD

0.25 CME

Clinical Applications of Anti-Histamine Drugs (Part 2)/Common Cold

19:41

Ahmed Zaafran, MD

1.25 CME

(Webinar) Peptic Ulcer Disease and the Role of PPIs

1:13:38

Sameer Islam, MD

Overview of the Pediatric Vaccination Schedules

1:56:21

Tammy Wang, MD

0.21 CME

Penicillin: Mechanism of Action

12:15

Dr. Mobeen Syed

0.75 CME

Sedation and Analgesia

51:09

Luis A Verduzco M.D.

0.12 CME

Nitric Oxide

07:12

Dr. Mobeen Syed

0.50 CME

How Dostarlimab Therapy Healed Colorectal Cancer

31:04

Dr. Mobeen Syed

Potential New Killer Cells for Cancer Immunotherapy

30:23

Dr. Mobeen Syed

Story of Ivermectin Nobel Prize

16:50

Dr. Mobeen Syed

1.00 CME

Opioid Receptor Activation and Tolerance (Pain Part 5)

53:40

Dr. Mobeen Syed

Omega-6 to Omega-3 Ratio

31:33

Dr. Mobeen Syed

Omega-3 Dietary Sources and Quantities

21:52

Dr. Mobeen Syed

Merck’s Molnupiravir (EIDD-281) Effective Against SARS-COV-2

29:11

Dr. Mobeen Syed

Maraviroc Mechanism of Action (MOA)

32:44

Dr. Mobeen Syed

Low Histamine Diets

19:50

Dr. Mobeen Syed

IVIg A High Level Overview

23:23

Dr. Mobeen Syed

Mixing Vaccine Types - UK Study

12:18

Dr. Mobeen Syed

Administration of Second Dose Of Moderna Vaccine After An Immediate Hypersensitivity Reaction to The First Dose

10:46

Dr. Mobeen Syed

Nasal Spray for Virus/SARS-COV-2 Reduction

21:28

Dr. Mobeen Syed

How is AstraZeneca Vaccine Made

07:06

Dr. Mobeen Syed

Covaxin, A Vaccine from India

30:56

Dr. Mobeen Syed

Sputnik Vaccine is 91.6% Effective

19:30

Dr. Mobeen Syed

Interferon Beta - A New Study

18:05

Dr. Mobeen Syed

Vitamin D, Dust and Covid-19

15:42

Dr. Mobeen Syed

Regeneron Antibody Cocktail

08:53

Dr. Mobeen Syed

0.50 CME

Macrolide - Azithromycin

24:12

Dr. Mobeen Syed

Famotidine (H2 Receptor Antagonist)

28:20

Dr. Mobeen Syed

Norepinephrine

32:19

Dr. Mobeen Syed

Favipiravir

26:05

Dr. Mobeen Syed

Iodine and Its Medical Uses

26:07

Dr. Mobeen Syed

Dexamethasone

28:41

Dr. Mobeen Syed

0.50 CME

COVID-19 and Aspirin

28:13

Dr. Mobeen Syed

Magnesium

35:04

Dr. Mobeen Syed

Melatonin

30:38

Dr. Mobeen Syed

Tocilizumab An IL6 Receptor Blocker

34:49

Dr. Mobeen Syed

Camostat Mesylate

25:14

Dr. Mobeen Syed

0.50 CME

NAC N-Acetylcysteine

27:41

Dr. Mobeen Syed

Convalescent Plasma For COVID-19 Patients

50:28

Dr. Mobeen Syed

Androgens Physiological and Pharmacological Aspects (Lecture 1)

29:33

Dr. Mobeen Syed

Androgens - What Controls Androgen Release (Lecture 2)

28:44

Dr. Mobeen Syed

Antiandrogens - A High-Level Overview (Lecture 3)

35:26

Dr. Mobeen Syed

Study - Antiandrogens Reduce COVID Hospitalization, Deaths, And Disease Progress

19:22

Dr. Mobeen Syed

Study - Antiandrogens (Dutasteride) For Mild COVID Cases

20:13

Dr. Mobeen Syed

Related Videos

All information contained in and produced by DrBeen corp is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease.

THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.

Click here for notice and disclaimer.

Copyright © 2015-2025 all rights reserved by DrBeen Corp